logo
West Lothian woman's decision to listen to her body could have been what saved her life

West Lothian woman's decision to listen to her body could have been what saved her life

Edinburgh Live18-05-2025

Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info
A West Lothian woman's decision to trust her gut and get her breasts checked could have been what saved her life.
Jill MacGregor, 59, was diagnosed with breast cancer on her 48th birthday back in 2013 after she went to the GP to get a twinge in her breast bone area checked out.
She was sent for a mammogram and what she thought to be a pulled muscle turned out to be a tear in her chest wall muscle - but while specialists were looking for the cause of her pain, they also found an abnormality.
"There was no lump, I had been exercising and I just had a little pain," she said.
"I just thought 'I wonder if I pulled a muscle' and if I'm honest, that probably went on for a few months of really not being too concerned. I think you justify it so I was almost like 'oh it's cycle related' but then I got to a stage where I thought 'you're thinking about this more, so just go and get it checked' so I did.
"My GP was absolutely fantastic, again, she was not in the least bit concerned but because I was at that age, I was 48, so still two years before I would be in the routine screening, she said to me, 'Do you know what, just as routine, I'll send you for a mammogram.
"She said, 'I'm not sending you because I think its anything, it just puts your mind at rest.' I had no worries at all about it and when I went back the consultant said to me, 'I think its been a wee tear in your chest wall muscle, but we just want to send you back along for another mammogram because there's just a wee area, completely unrelated to that that we want to check.'"
Jill went back for another mammogram and was told, on November 28, 2013: "You have breast cancer."
From there, her life was turned upside down and the Edinburgh fitness coach was booked in for a full mastectomy and a course of chemotherapy and radiation.
Thankfully, her treatment worked and she has been cancer free for over 10 years now, and urges others to listen to their bodies and advocate for themselves.
She said: "Don't ignore any symptoms, no matter how small it seems just go to your GP and get an appointment. If you're not happy with the outcome, ask again, go and see somebody else."
Jill has always been actively involved with Cancer Research and would lead the warmups for the Race for Life in Edinburgh and South Queensferry, even before she was diagnosed, but after going through cancer herself, she has only become more involved.
The latest fundraiser she is involved in is to raise money for is a cream tea in aid of Cancer Research taking place in Edinburgh on Saturday, June 7.
"Being able to run events which fundraise is better than just asking people to sponsor you," She continued. "Last year, ran the Paris Marathon to celebrate 10 years cancer free.
"We did lots of fundraising for that, we did quiz nights, afternoon teas, we did the lot and we raised over £6,000 that time so when Elaine said that they were doing the cream tea I just said 'count me in!'
"Through my classes I've been touched with so many of my own members that come to my classes going through the same journey and I'll say, for me 'that's 12 years ago' and sometimes it feels like yesterday and other times you think 'I've left it well and truly behind me' but I think for me, it's really important to be able to give back. I think that's why I'm still so heavily involved with cancer research."
Now she is urging others to come along and support Cancer Research at what is sure to be a fun and social afternoon tea.
She added: "We can all do our own little bit, and I know times are hard, I get that but it's just a nice social afternoon. All we're saying to people is, come along bring a few friends sit down have scones, cake, tea, a wee glass of fizz if you want - a nice afternoon for £6."
The afternoon tea will take place on Saturday, June 7, from 2.30-4pm at the Holy Cross Church on Davidsons Mains.
More information on the event and tickets can be purchased here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Edinburgh mum given heart-breaking diagnosis just two months after 50th birthday
Edinburgh mum given heart-breaking diagnosis just two months after 50th birthday

Edinburgh Live

time18 hours ago

  • Edinburgh Live

Edinburgh mum given heart-breaking diagnosis just two months after 50th birthday

Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info An Edinburgh woman was diagnosed with breast cancer just two months after she celebrated her 50th birthday. Gail Izat, an inspirational business leader, was guest of honour at Cancer Research UK's Race for Life, sounding the starter horn to send around 1,300 participants on the courses at Holyrood Park. The Standard Life Managing Director was diagnosed with breast cancer in August 2019. The disease then returned days before Christmas in 2022 and the mum-of-two is now in remission. She has vowed to do whatever she can do to continue spreading awareness and give others more tomorrows with their loved ones. Gail said: "I've had cancer twice but I've got through it twice thanks to life-saving science. 'When you've had cancer suddenly you realise you're not immortal and actually you have something that might kill you. At first having cancer felt like being admitted to a secret club I didn't want to belong to. I felt strongly that I didn't even want to talk to people about cancer until I found out more information about what I was actually facing, until I knew it was curable. 'But as time went on I started to believe I was going to get through the disease. And as I've recovered, I've found events like Race for Life offer a chance to meet people whose lives have also been touched by cancer. It offers a wonderful support and a sense of community.' Gail was cheered on by her colleagues and more than £201,300 was raised at Race for Life - vital funds that will enable scientists to find new ways to prevent, diagnose and treat cancer Linda Summerhayes, Cancer Research UK's spokeswoman in Scotland, said: 'We are incredibly grateful to everyone who took part in Race for Life Edinburgh. Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. 'No matter how cancer affects us, life is worth racing for. Sadly nearly 1 in 2 of us will get cancer in our lifetime** but all of us can support the research that will beat it. We're proud that Race for Life has had such a positive impact. Every pound raised supports our life-saving work, which has helped double cancer survival in the UK over the last 50 years. 'It was a fantastic day at Race for Life Edinburgh, full of emotion, courage, tears, laughter and hope as people celebrated the lives of those dear to them who have survived cancer and remembered loved ones lost to the disease. 'Now we're asking everyone who took part to return the money they're raised as soon as possible. Every donation, every pound raised will make a real difference. ' Andy Curran, Chief Executive of Standard Life, part of Phoenix Group, said: 'We are incredibly proud to continue as headline sponsor for Cancer Research UK's Race for Life, with the opportunity to encourage participation across the country. 'By working to raise funds for life-saving research, we can move towards a future where people live longer and better lives, free from the fear of cancer.'

Edinburgh Race for Life in Holyrood Park raises more than £200,000 for cancer research
Edinburgh Race for Life in Holyrood Park raises more than £200,000 for cancer research

Scotsman

time19 hours ago

  • Scotsman

Edinburgh Race for Life in Holyrood Park raises more than £200,000 for cancer research

Cancer Research UK said the money was vital in enabling scientists to find new ways to prevent, diagnose and treat cancer, helping to bring about a world where people live longer, better lives, free from the fear of cancer. Sounding the starting horn at this year's event was inspirational business leader Gail Izat, who overcame cancer twice. Ms Izat, who is a Standard Life managing director in Edinburgh, was diagnosed with breast cancer in August 2019, just two months after celebrating her 50th birthday. It was a shock when the disease returned days before Christmas in 2022. Now in remission, the mum of two has vowed to do everything she can to help 'give others more tomorrows with their loved ones'. She said: 'I've had cancer twice but I've got through it twice thanks to life-saving science. 'When you've had cancer suddenly you realise you're not immortal and actually you have something that might kill you. At first having cancer felt like being admitted to a secret club I didn't want to belong to. I felt strongly that I didn't even want to talk to people about cancer until I found out more information about what I was actually facing, until I knew it was curable. 'But as time went on I started to believe I was going to get through the disease. And as I've recovered, I've found events like Race for Life offer a chance to meet people whose lives have also been touched by cancer. It offers a wonderful support and a sense of community.' Standard Life fielded a team of 30 staff who completed Race for Life Edinburgh. Linda Summerhayes, Cancer Research UK's spokeswoman in Scotland, said: 'We are incredibly grateful to everyone who took part in Race for Life Edinburgh. 'No matter how cancer affects us, life is worth racing for. Sadly nearly one in two of us will get cancer in our lifetime, but all of us can support the research that will beat it. We're proud that Race for Life has had such a positive impact. Every pound raised supports our life-saving work, which has helped double cancer survival in the UK over the last 50 years. 'It was a fantastic day at Race for Life Edinburgh, full of emotion, courage, tears, laughter and hope as people celebrated the lives of those dear to them who have survived cancer and remembered loved ones lost to the disease.' 1 . Gathering in the park Hundreds gathered in Holyrood Park as Race For Life Edinburgh got under way. | TSPL Photo: Rhoda Morrison Photo Sales 2 . Fun warm-up Runners taking part in a fun warm up ahead of the race | TSPL Photo: Rhoda Morrison Photo Sales 3 . Starting line Business leader Gail Izat, who has overcome cancer twice, was guest of honour at Cancer Research UK's Race for Life, sounding the starter horn to send the runners on their way. | Cancer Research UK Photo Sales 4 . 10K line-up Those taking part in the 10K event line up at the start of the race | TSPL Photo: Rhoda Morrison Photo Sales Related topics: Cancer Research UK

Major discovery about 'invisible' breast tumours that are too small to show up on scans
Major discovery about 'invisible' breast tumours that are too small to show up on scans

Daily Mail​

time21 hours ago

  • Daily Mail​

Major discovery about 'invisible' breast tumours that are too small to show up on scans

Thousands of women have been thrown a lifeline thanks to a 'next generation' drug that can destroy breast cancer tumours, months before they even grow. The daily pill, known as camizestrant, stops cancer cells from developing, slowing the spread of the disease and delaying the need for gruelling chemotherapy. Around seven in ten breast cancer patients in the UK have a type of the disease known as HR positive HER-2 negative breast cancer—the most common form. Of these, around 40 per cent can develop an aggressive genetic mutation that makes their outlook incredibly bleak. But the 'transformational' trial found patients given the drug camizestrant saw their risk of the cancer progressing slashed by more than half. It was also the first worldwide study that showed blood tests, rather than scans, can pick up early signs of cancer returning. Doctors first used the test, known as a liquid biopsy, to spot changes in the cancer's DNA—when they found signs of an ESR1 mutation, some patients were given camizestrant, while others stayed on their usual treatment. Experts presenting the findings today at the American Society for Clinical Oncology conference (ASCO) in Chicago, hailed it a 'pivotal moment in breast cancer care' and 'truly fundamental shift in how we approach cancer'. The drug is already being fast-tracked for use in the US and has been sent for approval in the UK. Professor Nicholas Turner, an expert in molecular oncology at The Institute of Cancer Research, London and the Royal Marsden NHS Foundation Trust, who co-led the major trial, said: 'This is a pivotal moment in breast cancer care. 'This proactive approach also redefines how we think about drug resistance in this type of breast cancer. 'This is a potential new treatment strategy in oncology to treat developing resistance before it causes disease progression.' Professor Kristian Helin, chief executive of The Institute of Cancer Research, London, added: 'The results represent more than a clinical milestone—they represent a transformational shift in how we approach precision medicine. 'It is very exciting to see this technology being used to delay disease progression in patients and extend the benefits of treatment in patients with this type of advanced breast cancer and delay the need for chemotherapy for as long as possible. 'These breakthroughs are helping shape personalised breast cancer treatment, allowing doctors to adjust therapies earlier and improve patient outcomes.' In the trial, 3,325 patients HR positive HER-2 negative advanced breast cancer from 23 countries were screened for ESR1 mutations using a liquid biopsy every eight to 12 weeks. Of these, 315 women who tested positive for an ESR1 mutation were given either AstraZeneca's camizestrant and a medicine known as a CDK4/6 inhibitor or another hormone therapy as well as a CDK4/6 inhibitor. Researchers found those on the camizestrant combination slashed their risk of death or the cancer progressing by 56 per cent. The drug also kept the cancer at bay for 16 months on average compared to 9.2 months on standard treatment. Just one per cent of patients stopped taking the drug over side effects. Presenting the findings at ASCO, Susan Galbraith, executive vice president of oncology at AstraZeneca said the drug had now been given 'breakthrough therapy designation' by the Food and Drugs Administration in the US, helping to speed up regulatory review. 'We are having ongoing discussions with regulatory authorities including the UK', added. Dave Fredickson, AstraZeneca's executive vice president of oncology business unit, also said the drug demonstrated a 'truly fundamental shift in how we approach cancer care. 'We're moving away from a one size fits all era and targeting cancer early.' Meanwhile, Dr Catherine Elliott, director of research at Cancer Research UK, said: 'This study is a clear example of how blood tests are starting to transform cancer treatment. 'By tracking tiny traces of tumour DNA in the blood, researchers were able to spot early signs of treatment resistance and switch therapies before cancer had a chance to grow. 'It shows how circulating tumour DNA—or ctDNA—could help doctors make smarter, more timely treatment decisions. 'This approach could become an important part of how we personalise care for people with advanced breast cancer.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store